九典制药：预计2025年度营收同比增长10%—20%

Core Viewpoint - The company, Jiutian Pharmaceutical, anticipates a revenue growth of 10% to 20% for the fiscal year 2025, along with a similar increase in net profit excluding non-recurring items [1] Summary by Category - Revenue Forecast: Jiutian Pharmaceutical expects its operating revenue for 2025 to grow by 10% to 20% year-on-year [1] - Net Profit Forecast: The company projects a year-on-year increase of 10% to 20% in net profit after excluding non-recurring items for the same period [1]